Beta Bionics (BBNX) Operating Expenses (2024 - 2026)

Beta Bionics has disclosed Operating Expenses across 3 years of filings, most recently posting $44.5 million for Q2 2026.

• In Q2 2026, Operating Expenses rose 37.39% year-over-year to $44.5 million; the TTM figure through Jun 2026 stood at $152.4 million (up 45.71% YoY), while the FY2025 annual figure was $127.2 million, up 56.79% from the prior year.
• Operating Expenses came in at $44.5 million for Q2 2026 at Beta Bionics, up from $40.7 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $44.5 million in Q2 2026 to a low of $16.7 million in Q1 2024.
• Average Operating Expenses over 3 years is $29.4 million, with a median of $29.9 million recorded in 2025.
• Year-over-year, Operating Expenses jumped 65.8% in 2025 and surged 37.39% in 2026.
• Over 3 years, Operating Expenses stood at $24.7 million in 2024, then jumped by 41.83% to $35.1 million in 2025, then grew by 26.84% to $44.5 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $44.5 million in Q2 2026, $40.7 million in Q1 2026, and $35.1 million in Q4 2025.